Ustekinumab: In Psoriasis and Beyond—A Dermatological Perspective

ABSTRACT

Background: Ustekinumab is an interleukin 12/23 inhibitor, approved by the US-FDA for the management of moderate-tosevere plaque psoriasis and psoriatic arthropathy. Purpose: This review aims to describe the dermatological implications and applications of ustekinumab. Methodology: PubMed and Google Scholar were searched for scholarly articles related to ustekinumab and its utility in dermatology using the search terms “Ustekinumab” AND “Psoriasis” AND “dermatological diseases”. Studies utilising Ustekinumab in psoriasis and other dermatological indications were analysed and formulated into a systematic review discussing the utility of the drug in psoriasis, as well as other dermatological conditions. Results: Ustekinumab is a valuable biologic agent for the management of psoriasis and psoriatic arthropathy, as well as other dermatological disorders like hidradenitis suppurativa, lichen planus, pityriasis rubra pilaris, Behcet’s disease, lupus erythematosus, alopecia areata and pyoderma gangrenosum. Conclusion: Ustekinumab’s usage is not limited to psoriasis. Its benefit extends to many more dermatological conditions. It is considered to be the biologic of choice in childhood psoriasis and adult psoriatic patients with concurrent Crohn’s disease. Besides, it has an acceptable safety profile.

KEYWORDS

• Ustekinumab
• Psoriasis
• Hidradenitis suppurativa
• Pyoderma gangrenosum

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.1177/0976500X241240643Copy

RELATED ARTICLES

Matched on section and article type within this issue of J Pharmacol. Pharmacother..

• Review · VOLUME 15, ISSUE 2A Systematic Review and Meta-analysis of Selective Cyclooxygenase-2 Inhibitors and Non-selective Non-steroidal Anti-inflammatory Drugs for Acute GoutSwathy Govindaswamy, Kavya Ponnusamy, Indhumathi S., Vineeth Anil, Jayalakshmi Venugopal, Dhivya P. Sundaram · pp. 122–132Review ArticleSame type: Review
• Review · VOLUME 15, ISSUE 2Exploring the Novel Therapeutic Potential of N-acetylcysteine in Depression, Bipolar Disorders and AnxietyReuben P. Syiem, Julie B. Wahlang, Krishnamoorthi R., Pavan B. Kalyan, Diana Nahakpam, Arky Jane Langstieh · pp. 133–141Review ArticleSame type: Review
• Review · VOLUME 15, ISSUE 2Future of Pharmaceutical Industry: Role of Artificial Intelligence, Automation and RoboticsManoj Kumar T., Preethi B., Raja Shekhar Nunavath, Krishnaveni Nagappan · pp. 142–152Review ArticleSame type: Review
• Review · VOLUME 15, ISSUE 2A Review on Pharmacological Advancement of Ellagic AcidPougang Golmei, Sweta Kasna, Kumar Probin Roy, Sachin Kumar · pp. 93–104Review ArticleSame type: Review